Literature DB >> 11714780

Human V gamma 2V delta 2 T cells produce IFN-gamma and TNF-alpha with an on/off/on cycling pattern in response to live bacterial products.

L Wang1, H Das, A Kamath, J F Bukowski.   

Abstract

Whereas cytokine production in alphabeta T cells is rapidly regulated by exposure to peptide Ag, the mechanisms regulating cytokine production by gammadelta T cells are unknown. In this study, we demonstrate that human Vgamma2Vdelta2 T cells produce IFN-gamma and TNF-alpha as early as 2 h after Ag exposure, and that they produce these cytokines in a dose- and time- dependent manner in response to stimulation with a live bacterial product, iso-butylamine (IBA), but not to dead bacteria or LPS. gammadelta T cells began, ceased, and then resumed IFN-gamma and TNF-alpha generation in an on/off/on cycling pattern, both in vitro and in vivo, depending on the presence or absence of IBA. IFN-gamma and TNF-alpha, whose optimum production was dependent on IBA-stimulated gammadelta T cells, were critical for monocyte-mediated killing of Escherichia coli. By limiting cytokine production to periods of direct contact with live bacteria, gammadelta T cells focus their resources at the site of infection, while limiting systemic immunopathology. Thus, human gammadelta T cells may mediate innate resistance to extracellular bacteria via tightly regulated cytokine production without necessarily expanding in number.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714780     DOI: 10.4049/jimmunol.167.11.6195

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

Review 1.  gammadelta T cell subsets: a link between TCR and function?

Authors:  Rebecca L O'Brien; Willi K Born
Journal:  Semin Immunol       Date:  2010-05-06       Impact factor: 11.130

2.  Vγ4+ T cells regulate host immune response to West Nile virus infection.

Authors:  Thomas Welte; Judith Aronson; Bin Gong; Aparna Rachamallu; Nicole Mendell; Robert Tesh; Slobodan Paessler; Willi K Born; Rebecca L O'Brien; Tian Wang
Journal:  FEMS Immunol Med Microbiol       Date:  2011-11

Review 3.  Vgamma2Vdelta2+ T cells and anti-microbial immune responses.

Authors:  Zheng W Chen; Norman L Letvin
Journal:  Microbes Infect       Date:  2003-05       Impact factor: 2.700

Review 4.  Adaptive immune response of Vgamma2Vdelta2 T cells: a new paradigm.

Authors:  Zheng W Chen; Norman L Letvin
Journal:  Trends Immunol       Date:  2003-04       Impact factor: 16.687

Review 5.  Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy.

Authors:  Hamid Reza Mirzaei; Hamed Mirzaei; Sang Yun Lee; Jamshid Hadjati; Brian G Till
Journal:  Cancer Lett       Date:  2016-07-05       Impact factor: 8.679

Review 6.  Current progress in γδ T-cell biology.

Authors:  Jianlei Hao; Xiaoli Wu; Siyuan Xia; Zheng Li; Ti Wen; Na Zhao; Zhenzhou Wu; Puyue Wang; Liqing Zhao; Zhinan Yin
Journal:  Cell Mol Immunol       Date:  2010-10-11       Impact factor: 11.530

7.  Multieffector-functional immune responses of HMBPP-specific Vγ2Vδ2 T cells in nonhuman primates inoculated with Listeria monocytogenes ΔactA prfA*.

Authors:  Bridgett Ryan-Payseur; James Frencher; Ling Shen; Crystal Y Chen; Dan Huang; Zheng W Chen
Journal:  J Immunol       Date:  2012-06-27       Impact factor: 5.422

Review 8.  What rheumatologists need to know about innate lymphocytes.

Authors:  Mark A Exley; George C Tsokos; Kingston H G Mills; Dirk Elewaut; Ben Mulhearn
Journal:  Nat Rev Rheumatol       Date:  2016-09-02       Impact factor: 20.543

9.  Mucosal lymphatic-derived gammadelta T cells respond early to experimental Salmonella enterocolitis by increasing expression of IL-2R alpha.

Authors:  Jodi F Hedges; Diana L Buckner; Kerri M Rask; Hannah M M Kerns; Larissa O Jackiw; Theresa C Trunkle; David W Pascual; Mark A Jutila
Journal:  Cell Immunol       Date:  2007-06-15       Impact factor: 4.868

10.  TNF-alpha is a positive regulatory factor for human Vgamma2 Vdelta2 T cells.

Authors:  Haishan Li; Kun Luo; C David Pauza
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.